Literature DB >> 30093536

14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.

Bing Wang1, Rachel Underwood1, Anjali Kamath1, Colleen Britain1, Michael B McFerrin1, Pamela J McLean2, Laura A Volpicelli-Daley1, Robert H Whitaker3, William J Placzek3, Katelyn Becker4, Jiyan Ma4, Talene A Yacoubian5.   

Abstract

α-Synuclein (αsyn) is the key protein that forms neuronal aggregates in the neurodegenerative disorders Parkinson's disease (PD) and dementia with Lewy bodies. Recent evidence points to the prion-like spread of αsyn from one brain region to another. Propagation of αsyn is likely dependent on release, uptake, and misfolding. Under normal circumstances, this highly expressed brain protein functions normally without promoting pathology, yet the underlying endogenous mechanisms that prevent αsyn spread are not understood. 14-3-3 proteins are highly expressed brain proteins that have chaperone function and regulate protein trafficking. In this study, we investigated the potential role of the 14-3-3 proteins in the regulation of αsyn spread using two models of αsyn spread. In a paracrine αsyn model, 14-3-3θ promoted release of αsyn complexed with 14-3-3θ. Despite higher amounts of released αsyn, extracellular αsyn showed reduced oligomerization and seeding capability, reduced internalization, and reduced toxicity in primary mixed-gender mouse neurons. 14-3-3 inhibition reduced the amount of αsyn released, yet released αsyn was more toxic and demonstrated increased oligomerization, seeding capability, and internalization. In the preformed fibril model, 14-3-3 θ reduced αsyn aggregation and neuronal death, whereas 14-3-3 inhibition enhanced αsyn aggregation and neuronal death in primary mouse neurons. 14-3-3s blocked αsyn spread to distal chamber neurons not exposed directly to fibrils in multichamber, microfluidic devices. These findings point to 14-3-3s as a direct regulator of αsyn propagation, and suggest that dysfunction of 14-3-3 function may promote αsyn pathology in PD and related synucleinopathies.SIGNIFICANCE STATEMENT Transfer of misfolded aggregates of α-synuclein from one brain region to another is implicated in the pathogenesis of Parkinson's disease and other synucleinopathies. This process is dependent on active release, internalization, and misfolding of α-synuclein. 14-3-3 proteins are highly expressed chaperone proteins that interact with α-synuclein and regulate protein trafficking. We used two different models in which toxicity is associated with cell-to-cell transfer of α-synuclein to test whether 14-3-3s impact α-synuclein toxicity. We demonstrate that 14-3-3θ reduces α-synuclein transfer and toxicity by inhibiting oligomerization, seeding capability, and internalization of α-synuclein, whereas 14-3-3 inhibition accelerates the transfer and toxicity of α-synuclein in these models. Dysfunction of 14-3-3 function may be a critical mechanism by which α-synuclein propagation occurs in disease.
Copyright © 2018 the authors 0270-6474/18/388212-22$15.00/0.

Entities:  

Keywords:  14-3-3 proteins; Parkinson's disease; aggregation; dementia with Lewy bodies; exosome; α-synuclein

Mesh:

Substances:

Year:  2018        PMID: 30093536      PMCID: PMC6146494          DOI: 10.1523/JNEUROSCI.1134-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  73 in total

1.  14-3-3 proteins mediate an essential anti-apoptotic signal.

Authors:  S C Masters; H Fu
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

2.  Specification of 14-3-3 proteins in Lewy bodies.

Authors:  Daniela Berg; Olaf Riess; Antje Bornemann
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

3.  A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression.

Authors:  Kum-Joo Shin; Estelle A Wall; Joelle R Zavzavadjian; Leah A Santat; Jamie Liu; Jong-Ik Hwang; Robert Rebres; Tamara Roach; William Seaman; Melvin I Simon; Iain D C Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

4.  14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules.

Authors:  C Vincenz; V M Dixit
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

5.  Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates.

Authors:  Laura A Volpicelli-Daley; Kelvin C Luk; Virginia M-Y Lee
Journal:  Nat Protoc       Date:  2014-08-14       Impact factor: 13.491

6.  Hippocampal dysregulation of synaptic plasticity-associated proteins with age-related cognitive decline.

Authors:  Heather D VanGuilder; Julie A Farley; Han Yan; Colleen A Van Kirk; Matthew Mitschelen; William E Sonntag; Willard M Freeman
Journal:  Neurobiol Dis       Date:  2011-04-01       Impact factor: 5.996

7.  alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.

Authors:  N Ostrerova; L Petrucelli; M Farrer; N Mehta; P Choi; J Hardy; B Wolozin
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

8.  Caenorhabditis elegans screen reveals role of PAR-5 in RAB-11-recycling endosome positioning and apicobasal cell polarity.

Authors:  Julia Franziska Winter; Sebastian Höpfner; Kerstin Korn; Benjamin O Farnung; Charles R Bradshaw; Giovanni Marsico; Michael Volkmer; Bianca Habermann; Marino Zerial
Journal:  Nat Cell Biol       Date:  2012-05-27       Impact factor: 28.824

Review 9.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

10.  Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology.

Authors:  Michael B McFerrin; Xiaofei Chi; Gary Cutter; Talene A Yacoubian
Journal:  Ann Clin Transl Neurol       Date:  2017-06-07       Impact factor: 4.511

View more
  15 in total

1.  The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of α-synuclein.

Authors:  Rachel Underwood; Bing Wang; Christine Carico; Robert H Whitaker; William J Placzek; Talene A Yacoubian
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

2.  007 (x2)-3-3: 14-3-3 Targeted Compounds as Double Agents.

Authors:  Mary Gannon; Talene A Yacoubian
Journal:  Trends Pharmacol Sci       Date:  2020-05-10       Impact factor: 14.819

Review 3.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

4.  14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer's Disease Mouse Models.

Authors:  Mary Gannon; Bing Wang; Sara Anne Stringfellow; Stephan Quintin; Itzel Mendoza; Thanushri Srikantha; A Claire Roberts; Takashi Saito; Takaomi C Saido; Erik D Roberson; Talene A Yacoubian
Journal:  eNeuro       Date:  2022-06-24

5.  Clearance of an amyloid-like translational repressor is governed by 14-3-3 proteins.

Authors:  S Grace Herod; Annie Dyatel; Stefanie Hodapp; Marko Jovanovic; Luke E Berchowitz
Journal:  Cell Rep       Date:  2022-05-03       Impact factor: 9.995

Review 6.  Caught in the act: LRRK2 in exosomes.

Authors:  Shijie Wang; Andrew B West
Journal:  Biochem Soc Trans       Date:  2019-03-05       Impact factor: 5.407

Review 7.  14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases.

Authors:  F Sanders Pair; Talene A Yacoubian
Journal:  Trends Pharmacol Sci       Date:  2021-01-28       Impact factor: 14.819

8.  Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein.

Authors:  Yuan Guan; Xiaofang Zhao; Fengwei Liu; Shuxin Yan; Yalong Wang; Cuilian Du; Xiuyu Cui; Rena Li; Claire Xi Zhang
Journal:  Front Cell Neurosci       Date:  2020-06-12       Impact factor: 5.505

Review 9.  New Perspectives on Roles of Alpha-Synuclein in Parkinson's Disease.

Authors:  Guoxin Zhang; Yun Xia; Fang Wan; Kai Ma; Xingfang Guo; Liang Kou; Sijia Yin; Chao Han; Ling Liu; Jinsha Huang; Nian Xiong; Tao Wang
Journal:  Front Aging Neurosci       Date:  2018-11-22       Impact factor: 5.750

Review 10.  Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology.

Authors:  Francesca Longhena; Gaia Faustini; Maria Grazia Spillantini; Arianna Bellucci
Journal:  Int J Mol Sci       Date:  2019-01-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.